Ryan Sullivan
2019
Compensation breakdown
| Non-Equity Incentive Plan | $267,089 |
|---|---|
| Option Awards | $871,713 |
| Salary | $445,520 |
| Stock Awards | $1,471,902 |
| Other | $21,368 |
| Total | $3,077,592 |
Sullivan received $1.5M in stock awards, accounting for 48% of the total pay in 2019.
Sullivan also received $267.1K in non-equity incentive plan, $871.7K in option awards, $445.5K in salary and $21.4K in other compensation.
Rankings
In 2019, Ryan Sullivan's compensation ranked 3,984th out of 13,971 executives tracked by ExecPay. In other words, Sullivan earned more than 71.5% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 3,984 out of 13,971 | 72nd |
Division Manufacturing | 1,439 out of 5,695 | 75th |
Major group Chemicals And Allied Products | 509 out of 2,194 | 77th |
Industry group Drugs | 429 out of 1,880 | 77th |
Industry Pharmaceutical Preparations | 327 out of 1,392 | 77th |
Pay ratio
| Ryan Sullivan's Pay | $3,077,592 |
|---|---|
| Median Employee's Pay | $239,066 |
| Pay Ratio | 13to 1 |
In 2019, the annual total compensation of Ryan Sullivan was $3,077,592.
The annual total compensation of the median employee at Intercept Pharmaceuticals was $239,066.
The ratio of Ryan Sullivan's pay to the pay of median employee was therefore 13 to one.
Sullivan's colleagues
We found four more compensation records of executives who worked with Ryan Sullivan at Intercept Pharmaceuticals in 2019.
2019
Mark Pruzanski
Intercept Pharmaceuticals
Chief Executive Officer
2019
Jerome Durso
Intercept Pharmaceuticals
Chief Operating Officer
2019
Richard Kim
Intercept Pharmaceuticals
President, U.S. Commercial Strategic Marketing
2019
Sandip Kapadia
Intercept Pharmaceuticals